Mary Maluccio
Division Chief · Louisiana State University School of Medicine
Credentials: · · · · · · ·
History
- Present
Neuroendocrine Tumor Program (NOLANETS) and The Rare Cancer Program · Louisiana State University School of Medicine
- Present
Division of Surgical Oncology · Louisiana State University School of Medicine
1994–2002
Research
Cyclosporine induces cancer progression by a cell-autonomous mechanism
Nature · 1999 · 939 citations
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
Review · Current Anthropology · 2012 · First of 2 authors · Corresponding · 744 citations
Stereotactic body radiotherapy for primary hepatocellular carcinoma
International journal of radiation oncology · 2011 · 340 citations
- AC
10 papers · 2 as a fellow
- GG
8 papers
8 papers
- LB
8 papers
- CS
6 papers
- HC
6 papers
6 papers
- MW
Michael Weyant
5 papers
Grants
- 2009–2012
Metabolomics-Based Identification of Hepatocellular Cancer Biomarkers
National Cancer Institute · R21
PI · $376.1K · Purdue University
- 2006–2010
The Renin-Angiotensin System in Hepatitis and Hepatoma
National Cancer Institute · K22
Contact PI · $483.9K · Indiana University Indianapolis
- 1999
Optimizing Immunotherapy of Renal Cell Cancer
National Cancer Institute · F32
Contact PI · $71.4K · Weill Medical Coll of Cornell Univ
Clinical trials
- 2006–2015
Storage of Bile From Routine Procedures to Study Risk Factors
Principal investigator · Terminated
Indiana University
- 2025–2034
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
- 2022–2027
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network